Report: Catalyst Rx case study justifies Walgreens PBM network inclusion

WAG achieved a generic utilization rate of 69%, case study showed

ROCKVILLE, Md. — Catalyst Rx, the pharmacy benefits management subsidiary of Catalyst Health Solutions, on Friday took out a full-page ad in the Wall Street Journal touting the value of a Walgreens pharmacy to a large healthcare payer. Catalyst also released a case study touting that value, according to a report.

According to that case study, Walgreens achieved a generic utilization rate of 69% versus 67.7% for all other chains in the area, resulting in a cost-per-script savings of $3.30.

"Excluding Walgreens from the case study client pharmacy network would cause significant member disruption, create potential gaps in patient care and impact costs to the client, its employees, retirees and their dependents," Catalyst Rx stated. "As with all of our participating pharmacy partners, we recognize the services and the value delivered by Walgreens to its local community residents and are pleased to continue to include them in our network in 2012."

For a copy of the case study, click here.

Catalyst Rx in June completed its acquisition of Walgreens' pharmacy benefit management subsidiary.

Login or Register to post a comment.